中国药物评价
中國藥物評價
중국약물평개
Chinese Journal of Drug Evaluation
2014年
6期
350-355
,共6页
田金徽%赵晔%李金龙%葛龙%杨克虎
田金徽%趙曄%李金龍%葛龍%楊剋虎
전금휘%조엽%리금룡%갈룡%양극호
中药注射剂%吉西他滨%顺铂%非小细胞肺癌%网状Meta分析
中藥註射劑%吉西他濱%順鉑%非小細胞肺癌%網狀Meta分析
중약주사제%길서타빈%순박%비소세포폐암%망상Meta분석
Chinese traditional medicine injection%Gemcitabine%Cisplatin%Non-small cell lung cancer%Network Meta-analysis
目的:采用网状Meta分析评价12种中药注射剂联合吉西他滨和顺铂( GP)治疗非小细胞肺癌( NSCLC)的价值。方法:检索Science Citation Index Expanded ( SCI-EXPANDED)、EMBASE、PubMed、Cochrane Library、CancerLit、中国学术期刊网络出版总库( CNKI)、维普中文科技期刊全文数据库( VIP-CSJFD)、中国生物医学文献数据库( CBM)、万方数据期刊论文资源( WANFANG)、中国科学引文数据库( CSCD)和中国中医药等数据库,同时检索在研研究和相关学术组织网站,补充其他检索获取中药注射剂联合GP治疗NSCLC的随机对照试验( RCTs),按预先制定的纳入与排除标准筛选和纳入,并对纳入RCTs的质量进行质量评价,数据采用WinBugs软件进行数据分析。结果:共纳入12种中药注射剂,61个RCTs,共4480例患者。纳入RCTs的质量并不高,网状Meta分析结果显示:以GP化疗方案为共同干预措施,复方苦参注射液+GP和艾迪注射液+GP分别与得力生注射液+GP在有效率方面和康莱特注射液+GP在恶心呕吐发生率方面的差异有统计学意义,而其他注射液+GP之间的差异无统计学意义;在生活质量和白细胞减少方面,12种中药注射剂之间的差异无统计学意义。结论:基于网状Meta分析和测量指标排序核密度结果,蟾酥注射液、消癌平注射液和康艾注射液较其他9种中药注射剂相对有效。
目的:採用網狀Meta分析評價12種中藥註射劑聯閤吉西他濱和順鉑( GP)治療非小細胞肺癌( NSCLC)的價值。方法:檢索Science Citation Index Expanded ( SCI-EXPANDED)、EMBASE、PubMed、Cochrane Library、CancerLit、中國學術期刊網絡齣版總庫( CNKI)、維普中文科技期刊全文數據庫( VIP-CSJFD)、中國生物醫學文獻數據庫( CBM)、萬方數據期刊論文資源( WANFANG)、中國科學引文數據庫( CSCD)和中國中醫藥等數據庫,同時檢索在研研究和相關學術組織網站,補充其他檢索穫取中藥註射劑聯閤GP治療NSCLC的隨機對照試驗( RCTs),按預先製定的納入與排除標準篩選和納入,併對納入RCTs的質量進行質量評價,數據採用WinBugs軟件進行數據分析。結果:共納入12種中藥註射劑,61箇RCTs,共4480例患者。納入RCTs的質量併不高,網狀Meta分析結果顯示:以GP化療方案為共同榦預措施,複方苦參註射液+GP和艾迪註射液+GP分彆與得力生註射液+GP在有效率方麵和康萊特註射液+GP在噁心嘔吐髮生率方麵的差異有統計學意義,而其他註射液+GP之間的差異無統計學意義;在生活質量和白細胞減少方麵,12種中藥註射劑之間的差異無統計學意義。結論:基于網狀Meta分析和測量指標排序覈密度結果,蟾酥註射液、消癌平註射液和康艾註射液較其他9種中藥註射劑相對有效。
목적:채용망상Meta분석평개12충중약주사제연합길서타빈화순박( GP)치료비소세포폐암( NSCLC)적개치。방법:검색Science Citation Index Expanded ( SCI-EXPANDED)、EMBASE、PubMed、Cochrane Library、CancerLit、중국학술기간망락출판총고( CNKI)、유보중문과기기간전문수거고( VIP-CSJFD)、중국생물의학문헌수거고( CBM)、만방수거기간논문자원( WANFANG)、중국과학인문수거고( CSCD)화중국중의약등수거고,동시검색재연연구화상관학술조직망참,보충기타검색획취중약주사제연합GP치료NSCLC적수궤대조시험( RCTs),안예선제정적납입여배제표준사선화납입,병대납입RCTs적질량진행질량평개,수거채용WinBugs연건진행수거분석。결과:공납입12충중약주사제,61개RCTs,공4480례환자。납입RCTs적질량병불고,망상Meta분석결과현시:이GP화료방안위공동간예조시,복방고삼주사액+GP화애적주사액+GP분별여득력생주사액+GP재유효솔방면화강래특주사액+GP재악심구토발생솔방면적차이유통계학의의,이기타주사액+GP지간적차이무통계학의의;재생활질량화백세포감소방면,12충중약주사제지간적차이무통계학의의。결론:기우망상Meta분석화측량지표배서핵밀도결과,섬소주사액、소암평주사액화강애주사액교기타9충중약주사제상대유효。
Objective:To assess the clinical effects and safety of Chinese herb injection(CHI) combined gemcitabine and cisplatin ( GP) for non-small cell lung cancer( NSCLC).Methods:The relative randomized controlled trials ( RCTs) of CHIs were searched from Science Citation Index Expanded ( SCI-EXPANDED) ,PubMed,EMBASE, Cochrane Library, CancerLit, Chinese Knowledge Infrastruc-ture(CNKI), Chinese Scientific Journals Fulltext Database(VIP-CSJFD),Chinese Biomedical Literature Database(CBM),Wan-Fang Database( WANFANG) ,Chinese Science Citation Database( CSCD) and Traditional Chinese Medical Database System.The related refer-ences and website were also traced.The RCTs were screened according to the predefined inclusion and exclusion criteria, the related items were used to assess the quality of RCTs, data were analyzed by WinBugs software.Results:61 RCTs including 4480 patients and 12 CHIs were finally included.The quality of included RCTs were not high.The results of network Meta-analyses showed that,combined with GP, there were significant difference between compound matrine injection and ranglaite injection in efficacy,aidi injection and ranglaite injec-tion in efficacy, compound matrine injection and kanglaite injection in nausea and vomiting, aidi injection and kanglaite injection in nau-sea and vomiting,but no difference between other CHIs in efficacy and nausea and vomiting.At the same time, there were no difference between 12 CHIs in quality of life and leukopenia.Conclusion:Based on the results of network Meta-analysis and rank,chansu injection, xiao'aiping injection and kangai injection were more than other 9 CHIs.